APREA Therapeutics Board Members Pump Up Stakes With Zero‑Cost Stock Grants as Insiders Signal Confidence in Biotech Pipeline
Insider buying surges at APREA Therapeutics, signaling board confidence amid low prices and quiet volatility—what this means for investors.
4 minutes to read